A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2011
12/14/2011	CN101305982B 局部凝胶给药体系 Topical gel delivery system
12/14/2011	CN101300001B 奈拉美仙的修饰释放型骨架片剂 Naira cents modified-release matrix tablets
12/14/2011	CN101277695B 作为抗菌剂的喹啉衍生物 Quinoline derivatives as antibacterial agents
12/14/2011	CN101277688B 包含甲福明和维达列汀的配制物 Contains metformin and vildagliptin formulation
12/14/2011	CN101273988B 氨基咪唑甲酰胺和5-氨基或取代的氨基1,2,3-三唑的盐在制备治疗和预防肿瘤药物中的用途 Aminoimidazole carboxamide and 5-amino or substituted amino 1,2,3-triazole salt thereof in the manufacture of a medicament for the treatment and prevention of cancer of use
12/14/2011	CN101269055B 盐酸氨溴索口腔崩解片及其制备方法 Ambroxol hydrochloride orally disintegrating tablets and preparation method
12/14/2011	CN101265266B 青藤碱衍生物及其制备方法和应用 Sinomenine derivative and its preparation method and application
12/14/2011	CN101248070B 7-氨基亚烷基-杂环喹诺酮和萘啶酮 7- aminoalkylene - quinolone and nalidixic heterocyclic ketone
12/14/2011	CN101243184B 用于治疗或预防免疫缺陷病毒感染的核酸 For nucleic acid treatment or prevention of immunodeficiency virus infection
12/14/2011	CN101238109B 作为离子通道调节剂的茚满衍生物 Ion channel modulators as indene full derivative
12/14/2011	CN101218234B 作为代谢型谷氨酸受体的正变构调节剂的吡咯衍生物 As a metabotropic glutamate receptor positive allosteric modulators of pyrrole derivatives
12/14/2011	CN101193633B 噻吩并吡啶血小板聚集抑制剂制剂 Thienopyridine platelet aggregation inhibitor preparations
12/14/2011	CN101181266B 一种联苯苄唑乳胶剂及其制备方法 A benzyl yl latex and preparation method biphenyls
12/14/2011	CN101164538B 羧胺三唑类化合物及其盐在制备治疗疼痛性疾病和/或炎症性疾病的药物中的应用 Carboxyamidotriazole compounds and salts thereof in the preparation of the treatment of pain disorders and / or inflammatory diseases of the medicament
12/14/2011	CN101152174B 一种稳定的利福霉素钠注射液的处方及制备方法 A stable rifamycin sodium injection of prescription and preparation methods
12/14/2011	CN101137748B 粘液瘤病毒与雷帕霉素的组合在治疗性处理中的应用 Combination with rapamycin myxoma virus used in the therapeutic treatment of
12/14/2011	CN101124322B 用于治疗青光眼的血清淀粉状蛋白A的RNAi抑制 RNAi for the treatment of glaucoma serum amyloid A inhibitory
12/14/2011	CN101111483B Igf-1r抑制剂 Igf-1r inhibitor
12/14/2011	CN101108001B 保健功能食品 Health functional food
12/14/2011	CN101102988B 来自长链多不饱和脂肪酸的氧脂素及其制备和使用方法 From long-chain polyunsaturated fatty acids and lignans oxygen preparation and method of use
12/14/2011	CN101089010B 2＇-氟代核苷 2'-fluoro nucleosides
12/14/2011	CN101069685B 固体口服剂型药物 The solid oral dosage form pharmaceutical
12/14/2011	CN101066286B 具有抗胃溃疡功能的北沙参提取物及其制备方法 With anti-ulcer functional littoralis extract and its preparation method
12/14/2011	CN101056626B 利用5-氨基乙酰丙酸衍生物治疗痤疮 The use of 5-aminolevulinic acid derivatives for the treatment of acne
12/14/2011	CN101052390B 功能性消化道障碍预防·改善药以及食品 Functional gastrointestinal disorders · improving drug prevention and food
12/14/2011	CN101043894B 餐后血中中性脂肪的上升抑制剂以及含有其的食品 Postprandial increase in blood neutral fat inhibitor and foods containing it
12/14/2011	CN101035772B 用作β-分泌酶(BACE)抑制剂的2-氨基喹唑啉衍生物 2-amino-quinazoline derivatives are useful as β- -secretase (BACE) inhibitor
12/14/2011	CN101035575B 用于防止脊髓粘连的由硫酸化透明质酸和吉兰糖胶组成的生物材料 For preventing adhesion of the spinal cord by sulfated hyaluronic acid and gellan gum biomaterials
12/13/2011	USRE43029 Process for preparing a creatine heterocyclic acid salt and method of use
12/13/2011	US8076516 Amine derivative compounds for treating ophthalmic diseases and disorders
12/13/2011	US8076515 Process for the production of 2-[4-(3- and 2-fluorobenzyloxy) benzylamino] propanamides
12/13/2011	US8076514 Dipeptidyl peptidase IV inhibitors; Type II diabetes; 2-[(2S,3R)-3-Amino-2-hydroxy-4-(2,4,5-trifluoro-phenyl)-butyl]-N-tert-butyl-4-chloro-benzamide Hydrochloride
12/13/2011	US8076491 Compounds that inhibit (block) bitter taste in composition and use thereof
12/13/2011	US8076490 Epothilones C, D, E, and F, preparation and compositions
12/13/2011	US8076489 5-hydroxy-benzothiazole derivatives having beta-2-adrenoreceptor agonist activity
12/13/2011	US8076488 Antiproliferative agents; angiogenesis inhibitors; anticancer agents
12/13/2011	US8076485 Methylphenidate derivatives and uses of them
12/13/2011	US8076483 Process for the preparation of pure risedronic acid or salts
12/13/2011	US8076482 3,3′-spiroindolinone derivatives
12/13/2011	US8076479 useful as cyclin-dependent kinase inhibitor compounds; minimizes the need for chromatographic purification of intermediates, and utilizes fewer changes of solvent systems
12/13/2011	US8076477 Adsorbents for protein purification
12/13/2011	US8076471 RNAi expression constructs
12/13/2011	US8076466 Saccharidic fluorescent substrates, their process of preparation and their use
12/13/2011	US8076454 Modulating the expression of a gene in a host cell for applications such as gene therapy, large scale production of proteins and antibodies, cell-based high throughput screening assays, functional genomics and regulation of traits in transgenic organisms
12/13/2011	US8076377 N,N-dimethyl imidodicarbonimidic diamide dicarboxylate, method for producing the same and pharmaceutical compositions comprising the same
12/13/2011	US8076376 Aniline sulfonamide derivatives and their uses
12/13/2011	US8076375 Methods of inhibiting poxvirus growth
12/13/2011	US8076374 Glucagon receptor antagonists, preparation and therapeutic uses
12/13/2011	US8076373 Method for treating mammalian diseases and injuries caused by the over-expression of peroxynitrite
12/13/2011	US8076372 Acythiols and component thiol compositions as anti-HIV and anti-retroviral agents
12/13/2011	US8076371 Gallium compositions for the treatment of liver cancer and methods of use
12/13/2011	US8076370 Antimicrobial agents
12/13/2011	US8076369 N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses
12/13/2011	US8076368 Percutaneous absorption type cerebral protective agent
12/13/2011	US8076367 Benzimidazolylidene propane-1,3-dione derivative or salt thereof
12/13/2011	US8076366 Forms of bendamustine free base
12/13/2011	US8076365 Viral polymerase inhibitors
12/13/2011	US8076364 Trisubstituted amine compound
12/13/2011	US8076363 Isothiazolone-containing preservative with improved effectiveness
12/13/2011	US8076362 Crystal modification A of 1-(2,6-difluorobenzyI)-1 H-1,2,3-triazole-4-carboxamide and dosage forms and formulations thereof
12/13/2011	US8076361 Form of S-omeprazole
12/13/2011	US8076360 Indoles
12/13/2011	US8076359 Renin inhibitors
12/13/2011	US8076358 6-substituted-thio-2-amino-quinoline derivatives useful as inhibitors of β-secretase (BACE)
12/13/2011	US8076357 Compositions of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
12/13/2011	US8076356 Triazolopyridinylsulfanyl derivatives as P38 map kinase inhibitors
12/13/2011	US8076355 2-heteroarylcarboxylic acid amides
12/13/2011	US8076354 Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors
12/13/2011	US8076353 Inhibition of VEGF translation
12/13/2011	US8076352 Administration of carboline derivatives useful in the treatment of cancer and other diseases
12/13/2011	US8076351 Camptothecin derivatives with antitumor activity
12/13/2011	US8076350 3H-(4's)-1'-azaspiro[benzofuran-2,4']-tricyclo[3.3.1.13,7]decane; for therapy of memory disorder, cognitive disorder, neurodegeneration, and neurodevelopmental disorder; attention deficit disorder, attention deficit hyperactivity disorder (ADHD), Alzheimer's disease (AD), mild cognitive impairment
12/13/2011	US8076349 Such as (3S,4S)-3-[3-(4-Methanesulfonylbenzyl)-bicyclo[3.2.1]-2,4-dioxo-1 alpha ,3,8-triaza-spiro[4.5]dodec-8-ylmethyl]-4-phenyl-pyrrolidine-1-carboxylic acid tert-butyl ester; inflammation; HIV
12/13/2011	US8076348 Acylguanidine derivative or salt thereof
12/13/2011	US8076347 (-)-(2S,4S)-1-(2-hydroxymethyl-1,3-dioxolan-4-yl)cytosine (OddC); "L"-nucleoside that exhibits anti-tumor activity; anticarcinogenic agent for non-small cell lung cancer, colon, breast, prostate, ovarian, CNS, renal, and lymphoma cancer, leukemia, melanoma
12/13/2011	US8076346 Composition and method for improved bioavailability and enhanced brain delivery of 5,5-diphenyl barbituric acid
12/13/2011	US8076345 2-cyanophenyl-7,8-dihydro-5H-pyrido[4,3-d]pyrimidine compounds, compositions and uses thereof
12/13/2011	US8076344 Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme
12/13/2011	US8076342 Malonate salt of 4-((1R,3S)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and uses of same
12/13/2011	US8076341 Compounds and use thereof
12/13/2011	US8076340 Derivatives of 5-pyridazinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics
12/13/2011	US8076339 Pyridazinyl amine derivatives, the use thereof in the preparation of picorna virus inhibitors
12/13/2011	US8076338 Such as 6-(4-phenylpiperazin-1-yl)-9H-purine; cell proliferation/differentiation
12/13/2011	US8076337 Antitumoral derivatives of ET-743
12/13/2011	US8076336 Triazolopyridazines as PAR1 inhibitors, production thereof, and use as medicaments
12/13/2011	US8076335 Processes of making pharmaceutical formulations of antineoplastic agents
12/13/2011	US8076334 Prodrugs of thyroid hormone analogs
12/13/2011	US8076333 Fast acting naratriptan composition
12/13/2011	US8076332 N- (2-aminophenyl) benzamide derivative having urea structure
12/13/2011	US8076331 Substituted pyridazine derivatives
12/13/2011	US8076330 Dipeptidyl peptidase-IV inhibitors
12/13/2011	US8076329 Histamine H3-receptor ligands and their therapeutic applications
12/13/2011	US8076327 Condensed imidazole derivatives as aldosterone synthase inhibitors
12/13/2011	US8076326 N-phenyl- (piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor
12/13/2011	US8076325 1,2,4,5-tetrahydro-3H-benzazepine compounds, a process for their preparation and pharmaceutical compositions containing them
12/13/2011	US8076324 Di(hetero)arylcyclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising them
12/13/2011	US8076323 Anti-inflammatory agents
12/13/2011	US8076322 [6,6] and [6,7]-bicyclic GPR119 G protein-coupled receptor agonists
12/13/2011	US8076321 Compositions for treatment of systemic mastocytosis
12/13/2011	US8076320 Crystalline forms of a pharmaceutical compound

1 ... 1442 1443 1444 1445 1446 1447 1448 1449 1450 1451 1452 1453 1454 1455 1456 1457 1458 1459 1460 1461 1462 ... 7860